Moscow, Russia

Sergei S Trophimov

This inventor holds 1 USPTO granted patent. Top assignee: Russian-American Institute for New Drug Development. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei S Trophimov. Retrieved from https://idiyas.com/inventor/sergei-s-trophimov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sergei S Trophimov

Introduction

Sergei S Trophimov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of psychotropic substances, particularly in the development of compounds that enhance learning and memory. His work is characterized by a focus on biologically active N-acylprolydipeptides.

Latest Patents

Trophimov holds a patent for "Biologically active n-acylprolydipeptides having antiamnestic." This novel class of substances possesses psychotropic activity and is designed to facilitate learning and memory. The N-acyl-prolyldipeptides of the invention have a specific formula that includes various alkyl and aryl groups, showcasing the complexity and potential of his research. He has 1 patent to his name.

Career Highlights

Trophimov is affiliated with the Russian-American Institute for New Drug Development. His work at this institute emphasizes the importance of innovative drug development and the potential applications of his discoveries in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Tatiana A Gudasheva and Taisija L Garibova, contributing to a rich environment of research and development.

Conclusion

Sergei S Trophimov's contributions to the field of psychotropic substances highlight his innovative spirit and dedication to enhancing cognitive functions. His work continues to pave the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…